Edition:
United Kingdom

Halyard Health Inc (HYH.N)

HYH.N on New York Stock Exchange

48.96USD
7:37pm GMT
Change (% chg)

$-0.41 (-0.83%)
Prev Close
$49.37
Open
$49.55
Day's High
$49.80
Day's Low
$48.96
Volume
20,744
Avg. Vol
97,514
52-wk High
$50.93
52-wk Low
$35.25

Chart for

About

Halyard Health, Inc. is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare... (more)

Overall

Beta: --
Market Cap(Mil.): $2,154.29
Shares Outstanding(Mil.): 46.79
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 32.18 16.44
EPS (TTM): -- -- --
ROI: -- 13.94 10.61
ROE: -- 16.77 14.21

BRIEF-Owens & Minor Announces Updates On Pending Acquisition Of Halyard Health's S&IP Business

* OWENS & MINOR ANNOUNCES UPDATES ON PENDING ACQUISITION OF HALYARD HEALTH’S S&IP BUSINESS

05 Jan 2018

BRIEF-Halyard Health Board Approved Initial Phase Of Multi-Year Restructuring Plan

* HALYARD HEALTH-ON DEC 14, BOARD APPROVED INITIAL PHASE OF MULTI-YEAR RESTRUCTURING PLAN FOR DIVESTITURE OF SURGICAL AND INFECTION PREVENTION BUSINESS

20 Dec 2017

BRIEF-Halyard Health to sell S&IP business to Owens & Minor

* Halyard Health, Inc. announces sale of S&IP business to Owens & Minor, Inc. for $710 million

01 Nov 2017

BRIEF-Halyard Health Q3 adjusted earnings of $0.60/shr

* Halyard Health, Inc. announces third quarter 2017 results, raises full-year adjusted diluted eps outlook

01 Nov 2017

BRIEF-Owens & Minor to buy Halyard Health's surgical & infection prevention business for $710 mln

* Owens & Minor to acquire Halyard Health Inc's surgical & infection prevention (S&IP) business for $710 million in cash

01 Nov 2017

BRIEF-Halyard Health reports Q2 EPS of $0.36

* Halyard Health, Inc. Announces second quarter 2017 results, raises full-year adjusted diluted eps outlook

02 Aug 2017

Earnings vs. Estimates